company background image
A335810 logo

Precision Biosensor KOSDAQ:A335810 Stock Report

Last Price

₩4.11k

Market Cap

₩47.7b

7D

-8.7%

1Y

-25.5%

Updated

25 Apr, 2024

Data

Company Financials

Precision Biosensor, Inc.

KOSDAQ:A335810 Stock Report

Market Cap: ₩47.7b

A335810 Stock Overview

Precision Biosensor, Inc., an in-vitro diagnostics company, manufactures, distributes, and sells diagnostic reagents and analyzing devices in South Korea.

A335810 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Precision Biosensor, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Precision Biosensor
Historical stock prices
Current Share Price₩4,105.00
52 Week High₩7,300.00
52 Week Low₩4,095.00
Beta0.53
1 Month Change-16.14%
3 Month Change-23.27%
1 Year Change-25.50%
3 Year Change-78.05%
5 Year Changen/a
Change since IPO-87.37%

Recent News & Updates

Recent updates

Shareholder Returns

A335810KR Medical EquipmentKR Market
7D-8.7%7.6%3.4%
1Y-25.5%33.4%7.1%

Return vs Industry: A335810 underperformed the KR Medical Equipment industry which returned 33.4% over the past year.

Return vs Market: A335810 underperformed the KR Market which returned 7.1% over the past year.

Price Volatility

Is A335810's price volatile compared to industry and market?
A335810 volatility
A335810 Average Weekly Movement6.2%
Medical Equipment Industry Average Movement6.3%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.8%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A335810's share price has been volatile over the past 3 months.

Volatility Over Time: A335810's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2009102Hanshin Kimprecision-bio.com

Precision Biosensor, Inc., an in-vitro diagnostics company, manufactures, distributes, and sells diagnostic reagents and analyzing devices in South Korea. The company offers cartridges for cardiac, infection, and brain, as well as colorectal, pregnancy, and vitamin D deficiency indications; and immunochromatographic analyzers. It also provides thermostat devices for activating the reagent reactions; and IQC analyzers.

Precision Biosensor, Inc. Fundamentals Summary

How do Precision Biosensor's earnings and revenue compare to its market cap?
A335810 fundamental statistics
Market cap₩47.68b
Earnings (TTM)-₩4.49b
Revenue (TTM)₩20.39b

2.3x

P/S Ratio

-10.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A335810 income statement (TTM)
Revenue₩20.39b
Cost of Revenue₩12.71b
Gross Profit₩7.69b
Other Expenses₩12.18b
Earnings-₩4.49b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-386.61
Gross Margin37.69%
Net Profit Margin-22.02%
Debt/Equity Ratio57.5%

How did A335810 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.